The CDK4/6 inhibitors Palbociclib and Abemaciclib have shown synergy with Menin inhibitors in KMT2A‐ und NUP98‐rearranged as well as NPM1‐mutated AML.108, 117, 118. Here, NUP98 is linked to acute myeloid leukemia.